Novartis On Its ‘US First’ Commercial Plan

 
• By Jessica Merrill

US Innovative Medicines president Victor Bulto talked to Scrip about why the company is pivoting to a commercial strategy that prioritizes the US and what that means for developing and selling drugs.

upside down
Novartis is turning its commercial strategy on its head • Source: Shutterstock

More from Business

More from Scrip